The algorithm sorts patients into groups, who need grading and don't need grading. The ophthalmologists in the team/system can then focus on diagnosing and treating patients who actually need their time. In this way, RetinaLyze® reduces up to 60% of the manual workload.
RetinaLyze® provides instant results on automated screenings for Diabetic Retinopathy, Age-related Macular Degeneration and Glaucoma. The built-in telemedicine platform also allows operators to communicate with remote graders to receive manual assessments.
Security is important to us. As standard, all communication is encrypted. A middle man won’t be able to view or edit images, results or the client information. RetinaLyze is CE-marked and uses the highest level of encryption available today.
RetinaLyze® is a simple system and has been developed with the aim of being easy to use and easy to learn for clinicians as well as non-clinicians. The system can be easily adapted to fit the needs for a single retail store or clinic, a large chain of optometrists or hospitals as well as a rural screening camp.
Glaucoma is becoming an increasingly important cause of blindness, as the world’s population ages. New statistics gathered by WHO in 2002, show that glaucoma is now the second leading cause of blindness globally, after cataracts.
Danke! Thank you! Grazie! Merci! Gracias! Teşekkür ederiz! Bedankt! Спасибо! 谢谢! The RetinaLyze team thanks all visitors for a great fair in Munich and look forward to opti 2019!
Wow, 2017 was quite a year for RetinaLyze System A/S. We've screened over 150.000 people for Diabetic Retinopathy and AMD, won an award and launched both massive features and a host of enhancements.